Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Compare 6-month and 12-month emergency funds to determine the best target for your finances, weighing liquidity, security, and timelines.
24,819 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
A century-and-a-half-old Indiana company is drawing fresh investor attention with a plan to become the world's larges...
Curve rolls out Llamalend v2 on Optimism, expanding collateral and borrowing options. The upgrade comes with a 250,00...
AI-driven signals suggest XRP could break out to $1.40-$1.55 in the next 15 days, depending on clearing a key resista...
A transformative cross-border move blends traditional securities with crypto yields. Metaplanet’s acquisition of a Ja...
Older couples weighing a new life together face complex financial and legal decisions. This report outlines five esse...
Reve 2.0 promises layout-first AI imagery at 4K. This reve review: best image examines how it works, who benefits, an...
David Cordani is stepping aside as Cigna's CEO to become executive chairman, ending a 17‑year run that propelled the ...
A quiet neighborhood was rattled when scammers posed as federal agents and urged a couple to convert savings into gol...
A 22-year-old founder, backed by Lux Capital, is raising $30 million to launch American Perpetuals Exchange Corporati...
A retiree netting $36,000 a year from rentals faces ongoing taxation on most of his Social Security benefits due to p...
L’Oréal’s innovation chief says speed isn’t enough in AI-driven markets; enduring success comes from history, structu...